Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes

Journal of Experimental Medicine

Volumn 213, Issue 2, 2016, Pages 177-187

  Sarter, Kerstin ^a   Leimgruber, Elisa ^a,c   Gobet, Florian ^a   Agrawal, Vishal ^a   Dunand Sauthier, Isabelle ^a   Barras, Emmanuèle ^a   Mastelic Gavillet, Béatris ^a   Kamath, Arun ^a   Fontannaz, Paola ^a   Guéry, Leslie ^a   Do Valle Duraes, Fernanda ^a   Lippens, Carla ^a   Ravn, Ulla ^b   Santiago Raber, Marie Laure ^a,d   Magistrelli, Giovanni ^b   Fischer, Nicolas ^b   Siegrist, Claire Anne ^a   Hugues, Stéphanie ^a   Reith, Walter ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b NOVIMMUNE SA   (Switzerland)

^c EPFL   (Switzerland)

^d Tolerys SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYROPHILIN 2A2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; BTN2A2 PROTEIN, HUMAN; BUTYROPHILIN; CANCER VACCINE; DNA BINDING PROTEIN; MESSENGER RNA; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; REGULATORY FACTOR X TRANSCRIPTION FACTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; CELL LINE; DEFICIENCY; GENE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ANTIGEN-PRESENTING CELLS; BUTYROPHILINS; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DNA-BINDING PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HUMANS; IMMUNITY, CELLULAR; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PROTEINS; REGULATORY FACTOR X TRANSCRIPTION FACTORS; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84961159630     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20150435     Document Type: Article

References (30)

1. Afrache, H., P. Gouret, S. Ainouche, P. Pontarotti, and D. Olive. 2012. The butyrophilin (BTN) gene family: from milk fat to the regulation of the immune response. Immunogenetics. 64:781-794. http://dx.doi.org/10.1007/s00251-012-0619-z
2. Ammann, J.U., A. Cooke, and J. Trowsdale. 2013. Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes. J. Immunol. 190:5030-5036. http://dx.doi.org/10.4049/jimmunol.1203325
3. Arnett, H.A., and J.L. Viney. 2014. Immune modulation by butyrophilins. Nat. Rev. Immunol. 14:559-569. http://dx.doi.org/10.1038/nri3715
4. Arnett, H.A., S.S. Escobar, E. Gonzalez-Suarez, A.L. Budelsky, L.A. Steffen, N. Boiani, M. Zhang, G. Siu, A.W. Brewer, and J.L. Viney. 2007. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J. Immunol. 178:1523-1533. http://dx.doi.org/10.4049/jimmunol.178.3.1523
5. Azijli, K., E. Stelloo, G.J. Peters, and A.J. VAN DEN Eertwegh. 2014. New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies. Anticancer Res. 34:1493-1505.
6. Barnden, M.J., J. Allison, W.R. Heath, and F.R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34-40. http://dx.doi.org/10.1046/j.1440-1711.1998.00709.x
7. Boyden, L.M., J.M. Lewis, S.D. Barbee, A. Bas, M. Girardi, A.C. Hayday, R.E. Tigelaar, and R.P. Lifton. 2008. Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal γδT cells. Nat. Genet. 40:656-662. http://dx.doi.org/10.1038/ng.108
8. Chang, C.H., S. Guerder, S.C. Hong, W. van Ewijk, and R.A. Flavell. 1996. Mice lacking the MHC class II transactivator (CII TA) show tissuespecific impairment of MHC class II expression. Immunity. 4:167-178. http://dx.doi.org/10.1016/S1074-7613(00)80681-0
9. Clausen, B.E., J.M. Waldburger, F. Schwenk, E. Barras, B. Mach, K. Rajewsky, I. Förster, and W. Reith. 1998. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity. 8:143-155. http://dx.doi.org/10.1016/S1074-7613(00)80467-7
10. Cohen, I.R. 2014. Activation of benign autoimmunity as both tumor and autoimmune disease immunotherapy: a comprehensive review. J. Autoimmun. 54:112-117. http://dx.doi.org/10.1016/j.jaut.2014.05.002
11. Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell. 76:17-27. http://dx.doi.org/10.1016/0092-8674(94)90169-4
12. Krawczyk, M., E. Leimgruber, Q. Seguín-Estévez, I. Dunand-Sauthier, E. Barras, and W. Reith. 2007. Expression of RAB4B, a protein governing endocytic recycling, is co-regulated with MHC class II genes. Nucleic Acids Res. 35:595-605. http://dx.doi.org/10.1093/nar/gkl980
13. Krawczyk, M., Q. Seguín-Estévez, E. Leimgruber, P. Sperisen, C. Schmid, P. Bucher, and W. Reith. 2008. Identification of CII TA regulated genetic module dedicated for antigen presentation. PLoS Genet. 4:e1000058. http://dx.doi.org/10.1371/journal.pgen.1000058
14. Latchman, Y.E., S.C. Liang, Y. Wu, T. Chernova, R.A. Sobel, M. Klemm, V.K. Kuchroo, G.J. Freeman, and A.H. Sharpe. 2004. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA. 101:10691-10696. http://dx.doi.org/10.1073/pnas.0307252101
15. Malcherek, G., L. Mayr, P. Roda-Navarro, D. Rhodes, N. Miller, and J. Trowsdale. 2007. The B7 homolog butyrophilin BTN2A1 is a novel ligand for DC-SIGN. J. Immunol. 179:3804-3811. http://dx.doi.org/10.4049/jimmunol.179.6.3804
16. Muranski, P., A. Boni, P.A. Antony, L. Cassard, K.R. Irvine, A. Kaiser, C.M. Paulos, D.C. Palmer, C.E. Touloukian, K. Ptak, et al. 2008. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 112:362-373. http://dx.doi.org/10.1182/blood-2007-11-120998
17. Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 11:141-151. http://dx.doi.org/10.1016/S1074-7613(00)80089-8
18. Nishimura, H., T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hiai, N. Minato, and T. Honjo. 2001. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science. 291:319-322. http://dx.doi.org/10.1126/science.291.5502.319
19. Ogg, S.L., A.K. Weldon, L. Dobbie, A.J. Smith, and I.H. Mather. 2004. Expression of butyrophilin (Btn1a1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets. Proc. Natl. Acad. Sci. USA. 101:10084-10089. http://dx.doi.org/10.1073/pnas.0402930101
20. Reith, W., S. LeibundGut-Landmann, and J.M. Waldburger. 2005. Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 5:793-806. http://dx.doi.org/10.1038/nri1708
21. Sandstrom, A., C.M. Peigné, A. Léger, J.E. Crooks, F. Konczak, M.C. Gesnel, R. Breathnach, M. Bonneville, E. Scotet, and E.J. Adams. 2014. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. Immunity. 40:490-500. http://dx.doi.org/10.1016/j.immuni.2014.03.003
22. Shin, T., K. Yoshimura, T. Shin, E.B. Crafton, H. Tsuchiya, F. Housseau, H. Koseki, R.D. Schulick, L. Chen, and D.M. Pardoll. 2005. In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J. Exp. Med. 201:1531-1541. http://dx.doi.org/10.1084/jem.20050072
23. Smith, I.A., B.R. Knezevic, J.U. Ammann, D.A. Rhodes, D. Aw, D.B. Palmer, I.H. Mather, and J. Trowsdale. 2010. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. J. Immunol. 184:3514-3525. http://dx.doi.org/10.4049/jimmunol.0900416
24. Swanson, R.M., M.A. Gavin, S.S. Escobar, J.B. Rottman, B.P. Lipsky, S. Dube, L. Li, J. Bigler, M. Wolfson, H.A. Arnett, and J.L. Viney. 2013. Butyrophilinlike 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells. J. Immunol. 190:2027-2035. http://dx.doi.org/10.4049/jimmunol.1201760
25. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547. http://dx.doi.org/10.1016/1074-7613(95)90125-6
26. Vavassori, S., A. Kumar, G.S. Wan, G.S. Ramanjaneyulu, M. Cavallari, S. El Daker, T. Beddoe, A. Theodossis, N.K. Williams, E. Gostick, et al. 2013. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nat. Immunol. 14:908-916. http://dx.doi.org/10.1038/ni.2665
27. Viken, M.K., A. Blomhoff, M. Olsson, H.E. Akselsen, F. Pociot, J. Nerup, I. Kockum, A. Cambon-Thomsen, E. Thorsby, D.E. Undlien, and B.A. Lie. 2009. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun. 10:323-333. http://dx.doi.org/10.1038/gene.2009.13
28. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:985-988. http://dx.doi.org/10.1126/science.270.5238.985
29. Yamazaki, T., I. Goya, D. Graf, S. Craig, N. Martin-Orozco, and C. Dong. 2010. A butyrophilin family member critically inhibits T cell activation. J. Immunol. 185:5907-5914. http://dx.doi.org/10.4049/jimmunol.1000835
30. Zhang, Y., Y. Chung, C. Bishop, B. Daugherty, H. Chute, P. Holst, C. Kurahara, F. Lott, N. Sun, A.A. Welcher, and C. Dong. 2006. Regulation of T cell activation and tolerance by PDL2. Proc. Natl. Acad. Sci. USA. 103:11695-11700. http://dx.doi.org/10.1073/pnas.0601347103